Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 2
1993 2
1995 2
1996 3
1997 1
1998 2
1999 3
2000 4
2001 1
2002 1
2003 2
2004 1
2005 2
2007 1
2009 2
2010 2
2011 2
2013 2
2015 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
p28, a first in class peptide inhibitor of cop1 binding to p53.
Yamada T, Christov K, Shilkaitis A, Bratescu L, Green A, Santini S, Bizzarri AR, Cannistraro S, Gupta TK, Beattie CW. Yamada T, et al. Among authors: shilkaitis a. Br J Cancer. 2013 Jun 25;108(12):2495-504. doi: 10.1038/bjc.2013.266. Epub 2013 Jun 4. Br J Cancer. 2013. PMID: 23736031 Free PMC article.
Noncationic peptides obtained from azurin preferentially enter cancer cells.
Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, Chakrabarty AM, Green A, Bratescu L, Shilkaitis A, Beattie CW, Das Gupta TK. Taylor BN, et al. Among authors: shilkaitis a. Cancer Res. 2009 Jan 15;69(2):537-46. doi: 10.1158/0008-5472.CAN-08-2932. Cancer Res. 2009. PMID: 19147567 Free article.
A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt.
Mehta RR, Yamada T, Taylor BN, Christov K, King ML, Majumdar D, Lekmine F, Tiruppathi C, Shilkaitis A, Bratescu L, Green A, Beattie CW, Das Gupta TK. Mehta RR, et al. Among authors: shilkaitis a. Angiogenesis. 2011 Sep;14(3):355-69. doi: 10.1007/s10456-011-9220-6. Epub 2011 Jun 11. Angiogenesis. 2011. PMID: 21667138
36 results